The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
How I treat adenovirus in hematopoietic stem cell transplant recipients
Open accessAbstract
Adenovirus (AdV) infections are very common in the general pediatric population. The delayed clearance in young persons imposes a threat to immunocompromised patients after hematopoietic stem cell transplantation (HSCT), who can reactivate the virus, resulting in life-threatening disseminated disease. Although a definitive cure requires adequate immune reconstitution, 2 approaches appear to be feasible and effective to improve the outcomes of AdV infections. Strict monitoring with AdV quantitative polymerase chain reaction followed by preemptive treatment with low-dose (1 mg/kg) cidofovir 3 times a week, is effective in most cases to bridge the severely immunocompromised period shortly after HSCT, with acceptable toxicity rates. For centers who have the access, AdV-specific cytotoxic T cells can be the other important cornerstone of anti-AdV therapy with promising results so far. Methods to positively influence the reconstitution of the immune system after HSCT and optimizing new and currently available cellular immunotherapies will make HSCT safer against the threat of AdV infection/reactivation and associated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Min, D., Panoskaltsis-Mortari, A., Kuro-o, M., Holländer, G. A., Blazar, B. R., & Weinberg, K. I. (2007) · Blood · doi:10.1182/blood-2006-08-043794 · Cited by 214
Cited by
Adenovirus Infections in Immunocompetent and Immunocompromised Patients
Lion, T. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00116-13 · Cited by 861
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
Wold, W., & Toth, K. (2014) · Current Gene Therapy · doi:10.2174/1566523213666131125095046 · Cited by 555
Leen, A. M., Bollard, C. M., Mendizabal, A. M., Shpall, E. J., Szabolcs, P., Antin, J. H., Kapoor, N., Pai, S.-Y., Rowley, S. D., Kebriaei, P., et al. (2013) · Blood · doi:10.1182/blood-2013-02-486324 · Cited by 553
Self-citation
Metadata
- Authors
- Lindemans, C. A., Leen, A. M., & Boelens, J. J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2010-12-16
- Volume
- 116
- Issue
- 25
- Pages
- 5476-5485
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2047654743
- Cited by
- 232
- References
- 1
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How I treat adenovirus in hematopoietic stem cell transplant recipients. https://app.cochat.ai/papers/10.1182/blood-2010-04-259291
- The paper
- Lindemans, C. A., Leen, A. M., & Boelens, J. J. (2010). How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood. https://doi.org/10.1182/blood-2010-04-259291
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.